Background: Activated phosphoinositide 3-kinase (PI3K) δ syndrome (APDS) results from disease-associated variants in the PIK3CD and PIK3R1 genes that lead to hyperactivity of the PI3K delta pathway and progressive immune deficiency and/or dysregulation. This evidence concerns the gene PIK3CD and activated PI3K-delta syndrome.